Price movement over the last 24 hours
Aurora Cannabis Inc vs Enveric Biosciences Inc — how do they compare? Aurora Cannabis Inc trades at $2.7 (market cap $165.36M), while Enveric Biosciences Inc trades at $1.37 (market cap $5.84M). The key difference: Aurora Cannabis Inc is far larger — about 28.3× Enveric Biosciences Inc's market cap. Which is the better fit depends on your goals.
| ACB | ENVB | |
|---|---|---|
Market Cap | $165.36M | $5.84M |
Sector | Health | Health |
52-Week High | $6.23 | $17.40 |
52-Week Low | $2.67 | $1.28 |
Enterprise Value | $99.82M | $932.52K |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ENVB trades at $1.48, up 2.07% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, with negative ROE and ROA, yet consistently beat earnings expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies.
The outlook is mixed: strong analyst support (75% buy ratings) and positive clinical updates contrast with deep losses and bearish technicals. Key risks include clinical trial outcomes and cash burn, while institutional financing provides near-term stability. Upside depends on successful drug development.
Trailing returns across standard periods
Latest headlines on both assets
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →